Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday broker round-up UPDATE

Thu, 24th Oct 2013 09:25

Aquarius Platinum: Investec lowers target price from 48p to 42p and downgrades from hold to sell.ASOS: Citi increases target price from 5800p to 7000p reiterating its buy recommendation.BHP Billiton: Jefferies raises target price from 2350p to 2400p and keeps a buy recommendation.Clinigen: Investec increases target price from 313p to 469p reiterating its hold recommendation.Europa Oil & Gas Holdings: Northland Capital places its target price (prev.: 17.60p) under review, while retaining a buy recommendation.GlaxoSmithKline: Deutsche Bank reduces target price from 1850p to 1800p, while leaving its buy recommendation unchanged.Go-Ahead Group: Investec raises target price from 1645p to 1800p keeping a buy recommendation.Home Retail Group: Deutsche Bank ups target price from 160p to 185p and maintains a hold recommendation. Citi increases target price from 115p to 195p and upgrades to neutral.Kazakhmys: Jefferies cuts target price from 300p to 280p retaining a hold recommendation. Investec raises target price from 190p to 262p upgrading from sell to hold.Mitchells & Butlers: Alphavaue shifts target price from 371.10p to 371.60p upgrading from sell to reduce.Premier Oil: Liberum Capital upgrades to hold with a target price of 300p. FinnCap lowers target price from 410p to 405p, while its buy recommendation remains unchanged.Reckitt Benckiser: Investec raises target price from 4425p to 4700p keeping a hold recommendation.Rio Tinto: Jefferies increases target price from 3600p to 4000p maintaining its buy recommendation.RSA Insurance: Alphavalue lowers target price from 149.10p to 148.20p downgrading from buy to add.Sports Direct International: Citi increases target price from 780p to 825p and retains a buy recommendation.Sweett Group: WH Ireland moves target price from 60p to 75p keeping a buy recommendation. Westhouse Securities ups target price from 58p to 70p and stays with its buy recommendation.Tracsis: WH Ireland downgrades from buy to outperform with a target price of 220.Vedanta Resources: Jefferies reduces target price from 1350p to 1250p and stays with its hold recommendation.WPP Group: Bank of America ups target price from 1400p to 1480p and reiterates a buy recommendation. Investec places its target price (prev.: 1325p) under review, while leaving its buy recommendation unchanged.
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.